Piramal Pharma Limited (PPLPHARMA.NS) NSE

188.87

+1.14(+0.61%)

Updated at September 29 01:01PM

Currency In INR

Valuation

Market Cap302.24B
Enterprise Value345.79B
P/E Ratio257.27
PEG Ratio35.5
Price/Sales Ratio2.78
Price/Book Ratio3.11
Enterprise/Revenue3.25
Enterprise/EBITDA19.99

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.01
Operating Margin0.38

Management Effectiveness

Return On Assets0.01
Return On Equity0.01

Income Statement

Revenue91.51B
Revenue/Share69.31
Gross Profit59.2B
EBITDA14.04B
Net Income911.3M
Diluted EPS0.68

Balance Sheet

Total Cash5.21B
Total Cash/Share3.95
Total Debt48.56B
Total Debt/Equity0.6
Current Ratio1.54
Book Value Per Share61.66

Price History

52-Week Change-16.39
52-Week High307.9
52-Week Low181.73
Moving Average 50 Days196.37
Moving Average 200 Days211.1

Statistics

Average Volume4.43M
Shares Outstanding1.32B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.14
Trailing Annual Dividend Yield0.07
Payout Ratio0
Last Split Factor1023:1000
Last Split DateAugust 02, 2023